Cell Analysis Global Market Report 2022: Growing Focus on Personalized Medicine & Introduction of Advanced Technologies in Cell Analysis Presents…

Company Logo

Dublin, Aug. 17, 2022 (GLOBE NEWSWIRE) -- The "Cell Analysis Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

According to analysis, the cell analysis global market is expected to grow at a low single digit CAGR from 2022 to 2029 to reach $38,020.6 million by 2029. The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process are driving the cell analysis market.

The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others. Among the techniques, the PCR segment accounted for the largest revenue in 2022. The Sequencing segment is expected to grow at a double digit CAGR from 2022 to 2029.

The cell analysis products market is mainly segmented into consumables, instruments, software and services. Among these, consumables segment commanded the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. The software and services segment is expected to grow at a mid single digit CAGR from 2022 to 2029.

The consumables market is further sub-segmented into reagents, assay kits, microplates and others. Among the consumables sub-segments, the assay kits held the largest revenue in 2022. Reagents sub-segment is the fastest growing segment with a mid single digit CAGR from 2022 to 2029.

The application market is categorized based on processes, field, and by therapeutic area. In the process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening.

Story continues

Based on field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue of in 2022. Stem cell analysis is the fastest-growing segment at a mid single digit from 2022 to 2029.

The end-users market is segmented into hospitals & diagnostic laboratories, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, and others.

Market DynamicsDrivers and Opportunities

Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment

Increasing Government and Private Funding

Increasing Advancements in Cell Imaging Technologies Reduce the Cost and Time Consumption for the Drug Discovery Process

Growing Focus on Personalized Medicine

Introduction of Advanced Technologies in Cell Analysis

Increasing Merger and Acquisition Activities in Cell Analysis

Restraints & Threats

Lack of Skilled Personnel to Use Advanced Cell Analysis Instruments

Expensive Cell Analysis Instruments

Maintaining Consistency, Reproducibility of Assays and Lack of Standardization

Availability of Alternative Technologies

Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market

Key Topics Covered:

1 Executive Summary

2 Introduction

3 Market Analysis

4 Cell Analysis Global Market, Based on Techniques

5 Cell Analysis Global Market, Based on Products

6 Cell Analysis Global Market, Based on Application

7 Cell Analysis Global Market, Based on End-Users

8 Regional Market Analysis

9 Competitive Landscape

10 Major Player Profiles

Companies Mentioned

10X Genomics

1CellBio

Abbexa Ltd

Abbott Laboratories, Inc.

Abcam Plc.

Abnova Corporation

ABP Biosciences LLC

Adaptive Biotechnologies Corp.

Agilent Technologies Inc. (U.S.)

Aigenpulse

Akadeum Life Sciences

Akoya Biosciences, Inc.

Alit Lifesciences Co., Ltd

Altona Diagnostics GmbH

Analytik Jena AG (CyBio AG)

ArrayGen Technologies Pvt Ltd (India)

Art Robbins Instruments LLC (U.S.)

Aviva Bioscience (U.S.)

Axion Biosystems (CytoSMART Technologies B.V.) (U.S.)

Azenta Life Sciences (Brooks life sciences)

Becton Dickinson and Company

BennuBio Inc.

Berry Genomics Co., Ltd

BGI Group

Bico (Cellenion)

Bio View Ltd.

BioAgilytix Labs, LLC (Cambridge Biomedical Inc.)

Biochrom Ltd.

Biofluidica

BioinGentech

Bioneer Corporation

Bio-Rad Laboratories Inc.

Bioron GmbH

BioSkryb, Inc.

Bio-Techne Corporation

Biotium

bitBiome, Inc.

Blue-Ray Biotech

Brand GMBH

Bruker Corporation

Carl Zeiss AG

Etaluma Inc

Eurofins Scientific

Fluent BioSciences

Fluidigm Corporation

Fluxion Biosciences

GC biotech B.V.

Genomatix AG

GenXPro GmbH

Hamilton Company

Hausser Scientific

Helena Laboratories Corporation

Herolab GmbH

Hettich Lab Technology

HighQu GmbH

Horiba, Ltd

Illumina Inc.

Immunai

IncellDx

Inscopix

Insightful Science

IsoPlexis

Jasco Analytical Instruments

JEOL Ltd

Keyence Corporation

See the article here:
Cell Analysis Global Market Report 2022: Growing Focus on Personalized Medicine & Introduction of Advanced Technologies in Cell Analysis Presents...